Xeris Biopharma Inc.

3.20
-0.02 (-0.62%)
At close: Jan 17, 2025, 3:59 PM
3.24
1.16%
After-hours Jan 17, 2025, 06:13 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -62.26M -94.66M -94.66M -122.72M -91.14M -60.08M -26.55M -13.21M
Depreciation & Amortization 13.16M 12.67M 12.67M 1.88M 1.47M 320.00K 177.00K 116.00K
Stock-Based Compensation 10.72M 12.16M 11.38M 8.27M 6.48M 1.73M 499.00K 540.00K
Other Working Capital 9.92M -9.99M -9.99M 19.98M 7.01M 345.00K -140.00K -32.00K
Other Non-Cash Items -1.10M 3.52M 3.52M 961.00K 3.10M 560.00K 94.00K 49.00K
Deferred Income Tax -1.25M -1.42M -1.42M 1.11M 536.00K -414.00K n/a n/a
Change in Working Capital -6.29M -35.15M -35.15M 11.85M -2.80M 1.61M 1.12M -3.58M
Operating Cash Flow -47.02M -102.89M -102.89M -95.53M -80.56M -56.28M -24.66M -16.09M
Capital Expenditures -2.26M -524.00K -524.00K -1.08M -377.00K -1.51M -700.00K -35.00K
Acquisitions n/a n/a 38.47M 38.47M 377.00K n/a n/a n/a
Purchase of Investments -43.74M n/a -43.02M -43.02M -101.77M -68.85M n/a n/a
Sales Maturities Of Investments 40.00M 34.98M 34.98M 103.60M 74.75M 2.10M n/a n/a
Other Investing Acitivies n/a 34.98M 4.55M -27.03M -377.00K -66.75M n/a n/a
Investing Cash Flow -6.00M 34.46M 34.46M 97.96M -27.41M -68.26M -700.00K -35.00K
Debt Repayment n/a 102.72M n/a 69.75M 25.00M 35.00M n/a -32.00K
Common Stock Repurchased -1.01M -468.00K -534.00K -63.00K n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -604.00K -4.78M 781.00K -9.51M 55.53M 4.11M 35.14M 3.94M
Financial Cash Flow -1.61M 127.47M 127.47M 27.25M 126.06M 128.21M 35.14M 3.90M
Net Cash Flow -54.64M 59.04M 59.04M 29.67M 18.08M 3.67M 9.78M -12.22M
Free Cash Flow -49.29M -103.42M -103.42M -96.62M -80.94M -57.79M -25.36M -16.12M

Create Price Alert on XERS

Your price alert will notify you when the stock price is above 3.20.

Add to Watchlist